Cummings SR, Martin JS, McClung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756–65.

Article  CAS  PubMed  Google Scholar 

Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376:1713–22.

Article  CAS  PubMed  Google Scholar 

Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, et al. Tezepelumab in adults with uncontrolled asthma. N Engl J Med. 2017;377:936–46.

Article  CAS  PubMed  Google Scholar 

Lesokhin AM, Tomasson MH, Arnulf B, Bahlis NJ, Miles Prince H, Niesvizky R, et al. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results. Nat Med. 2023;29:2259–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu J, Song Y, Tian W. How to select IgG subclasses in developing anti-tumor therapeutic antibodies. J Hematol OncolJ Hematol Oncol. 2020;13:1–10.

Google Scholar 

Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: From structure to effector functions. Front Immunol. 2014;5:1–17.

Article  CAS  Google Scholar 

Rudge SR, Nims RW. ICH Q6B specifications: test procedures and acceptance criteria for biotechnological/biological products. ICH Quality Guidelines: An Implementation Guide. 2017 Sep 27:467–86.

Lemery SJ, Ricci MS, Keegan P, McKee AE, Pazdur R. FDA’s approach to regulating biosimilars. Clin Cancer Res. 2017;23:1882–5.

Article  PubMed  Google Scholar 

Kirchhoff CF, Wang X-ZM, Conlon HD, Anderson S, Ryan AM, Bose A. Biosimilars: key regulatory considerations and similarity assessment tools. Biotechnol Bioeng. 2017;114:2696–705.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding pharmaceutical quality by design. AAPS J. 2014;16:771–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patel HM, Noolvi MN, Sharma P, Jaiswal V, Bansal S, Lohan S, et al. Quantitative structure–activity relationship (QSAR) studies as strategic approach in drug discovery. Med Chem Res. 2014;23:4991–5007.

Article  CAS  Google Scholar 

Holm P, Allesø M, Bryder MC, Holm R. Q8 (R2) Pharmaceutical Development. ICH quality guidelines: an implementation guide. 2017 Sep 27:535–77.

Matikonda SS, McLaughlin R, Shrestha P, Lipshultz C, Schnermann MJ. Structure–activity relationships of antibody-drug conjugates: a systematic review of chemistry on the trastuzumab scaffold. Bioconjug Chem. 2022;33:1241–53.

Article  CAS  PubMed  Google Scholar 

Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, et al. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B. 2001;752:233–45.

Vlasak J, Ionescu R. Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods. Curr Pharm Biotechnol. 2008;9:468–81.

Article  CAS  PubMed  Google Scholar 

Liu S, Madren S, Feng P, Sosic Z. Characterization of the acidic species of a monoclonal antibody using free flow electrophoresis fractionation and mass spectrometry. J Pharm Biomed Anal. 2020;185: 113217.

Article  CAS  PubMed  Google Scholar 

Wang L, Wu H, Cao T, Li H, Shen P, Lu L, et al. Identification of structural origins of complex charge heterogeneity in therapeutic ACE2Fc fusion protein facilitated by free-flow isoelectric focusing. Eur J Pharm Biopharm. 2024;198: 114248.

Article  CAS  PubMed  Google Scholar 

McKinnon RA, Cook M, Liauw W, Marabani M, Marschner IC, Packer NH, et al. Biosimilarity and interchangeability: principles and evidence: a systematic review. BioDrugs. 2018;32:27–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mao Q, Pawliszyn J. Capillary isoelectric focusing with whole column imaging detection for analysis of proteins and peptides. J Biochem Biophys Methods. 1999;39:93–110.

Article  CAS  PubMed  Google Scholar 

Fekete S, Beck A, Veuthey J-L, Guillarme D. Ion-exchange chromatography for the characterization of biopharmaceuticals. J Pharm Biomed Anal. 2015;113:43–55.

Article  CAS  PubMed  Google Scholar 

Ponniah G, Nowak C, Neill A, Liu H. Characterization of charge variants of a monoclonal antibody using weak anion exchange chromatography at subunit levels. Anal Biochem. 2017;520:49–57.

Article  CAS  PubMed  Google Scholar 

Yan Y, Liu AP, Wang S, Daly TJ, Li N. Ultrasensitive characterization of charge heterogeneity of therapeutic monoclonal antibodies using strong cation exchange chromatography coupled to native mass spectrometry. Anal Chem. 2018;90:13013–20.

Article  CAS  PubMed  Google Scholar 

Sarin D, Kumar S, Rathore AS. Multiattribute monitoring of charge-based heterogeneity of recombinant monoclonal antibodies using 2D HIC-WCX-MS. Anal Chem. 2022;94:15018–26.

Article  CAS  PubMed  Google Scholar 

Liu AP, Yan Y, Wang S, Li N. Coupling anion exchange chromatography with native mass spectrometry for charge heterogeneity characterization of monoclonal antibodies. Anal Chem. 2022;94:6355–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hosken BD, Li C, Mullappally B, Co C, Zhang B. Isolation and characterization of monoclonal antibody charge variants by free flow isoelectric focusing. Anal Chem. 2016;88:5662–9.

Article  CAS  PubMed  Google Scholar 

Hanley DA, Adachi JD, Bell A, Brown V. Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract. 2012;66:1139–46.

Article  CAS  PubMed  Google Scholar 

Jadidi-Niaragh F. Potential of CD73 as a target for cancer immunotherapy. Immunotherapy. 2019;11:1353–5.

Article  CAS  PubMed  Google Scholar 

Brinkhaus M, Pannecoucke E, van der Kooi EJ, Bentlage AEH, Derksen NIL, Andries J, et al. The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement. Nat Commun. 2022;13:6073.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493–500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhattarai S, Pippel J, Scaletti E, Idris R, Freundlieb M, Rolshoven G, et al. 2-Substituted α, β-Methylene-ADP derivatives: potent competitive ecto-5′-nucleotidase (CD73) inhibitors with variable binding modes. J Med Chem. 2020;63:2941–57.

Article  CAS  PubMed  Google Scholar 

Xu X, O’Callaghan JA, Guarnero Z, Qiu H, Li N, Potocky T, et al. Low pKa of Lys promotes glycation at one complementarity-determining region of a bispecific antibody. Biophys J. 2022;121:1081–93.

Article  CAS  PubMed  PubMed Central  Google Scholar